DECISION SUPPORT UNIT
Level 8 BoQ Centre, 259 Queen St, Brisbane
1st Floor Blackburn House, 199 Grenfell St, Adelaide
Intranet site: http://intranet/nat/comp/dp/Nop/dsu/dsudefault.htm
SOP Bulletin No.103
27 March 2006
RELEASE NOTES - CCPS VERSION 2006/03
Version 2006/03 of the Medical Knowledge Base for CCPS was released into production
today. This Bulletin provides a summary of the new and amended SOPs that this version
of CCPS incorporates. This Bulletin also details changes to some existing rulebases and
commentary.
New SOPs incorporated
into CCPS
Nil
SOP amendments
incorporated into CCPS
Epilepsy
Malignant neoplasm of the pancreas
Peripheral neuropathy
Enhancements of CCPS
rulebases and commentary
Malignant neoplasm of bone and articular cartilage
Malignant neoplasm of the renal pelvis and ureter
Myelodysplastic disorder
Dental caries
Gingivitis
Motor neurone disease
Secondary parkinsonism
Buerger’s disease
Cholelithiasis
Nephrolithiasis
Additional amendments - not
noteworthy
Certain conditions with oestrogen factors
New SOPs incorporated into CCPS
Nil
SOP amendments incorporated into CCPS
Epilepsy
There are now 3 contentions in CCPS relating to head injury: a mild head injury, a
cerebral trauma through injury and a cerebral trauma through cranial surgery. The
first 2 types of head injury are mutually exclusive ie one head injury can’t be covered by
both contentions.
For information on this SoP refer to SoP Bulletin No. 99 of 22/12/05
Malignant neoplasm of the pancreas
For information on this SoP refer to SoP Bulletin No. 99 of 22/12/05
Peripheral neuropathy
The rulebase is now a more typical structure with factors no longer subsumed into ‘megafactors’. Consequently the specific peripheral neuropathy investigative questionnaires that
had been stored in CCPS Standard Letters have now been removed.
If a contention involves either methyl n-butyl ketone (MNBK), n-hexane or nitrous
oxide it can be considered under 2 factors - exposure to a volatile substance or inhalant
abuse or inhalant dependence. Nitrous oxide exposure can also be considered under
treatment with a drug from List 1.
Note that some drugs from Lists 1 and 2, some infections, some volatile substances, and
some systemic diseases apply in reasonable hypothesis cases only. Also acute
cholinergic poisoning can be due to organophosphorus ester or carbamate pesticide,
however the latter applies in reasonable hypothesis cases only. Relevant medical and
claimant questionnaires should be edited in balance of probability only cases.
There is a claimant questionnaire for volatile substances that refers to ‘in the nine months
before’ - 9 months allows for the maximum period of 6 months to incur the exposure and
the 3 months latency before clinical onset.
Also there are 3 drug factors- drugs from List 1, drugs from List 2 and cisplatin - which
share the same medical questionnaire and, if applicable, can be edited according to the
contention being investigated.
For information on this SoP refer to SoP Bulletin No. 99 of 22/12/05
Enhancements of CCPS rulebases and commentary
Kattenberg changes have also been made to the following conditions and the factors
specified:
 Malignant neoplasm of bone or articular cartilage (inhaling plutonium)
 Malignant neoplasm of the renal pelvis and ureter (smoking, phenacetin consumption)
 Myelodysplastic disorder (exposure to benzene)
 Dental caries (fluoride-free water)
 Gingivitis (not cleaning teeth, smoking)
 Motor neurone disease (smoking)
 Secondary parkinsonism (exposure to manganese, carbon disulphide and insecticides)
 Buerger’s disease (smoking)
 Cholelithiasis (oestrogen therapy)
 Nephrolithiasis (drugs)
Continuous improvement changes have been made to the oestrogen factor in certain
conditions.
Contact Officers for this bulletin:
Maureen Anderson
Gaynor Cavanagh
Susan Lee
Bernadette McCabe
5
4
5
4
0365
8331
0227
8393
Remember! If you are having any problems with SOPs, or SOPs in
CCPS, talk to us!